Home > Insider Trading > Filing (0001209191-16-095844)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1446372	M Paul Silva	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Svp & Corp Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-02-02	6,875	$0.01	21,812	No	4	A	Direct
Common Stock	Disposition	2016-02-03	2,300	$89.96	19,512	No	4	S	Direct
Common Stock	Disposition	2016-02-03	1,900	$91.07	17,612	No	4	S	Direct
Common Stock	Disposition	2016-02-03	662	$92.43	16,950	No	4	S	Direct
Common Stock	Disposition	2016-02-03	200	$93.06	16,750	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2016-02-02	20,625	$0.00	20,625	$91.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,625		2026-02-01	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	169	Indirect	401(k)

Footnotes

Restricted stock grant vesting on 2/2/2019, subject to acceleration if certain financial and/or business metrics are achieved.
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $89.96 (range $89.54 to $90.44).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $91.07 (range $90.56 to $91.48).
Open market sales reported on this line occurred at a weighted average price of $92.43 (range $91.79 to $92.72).
Open market sales reported on this line occurred at a weighted average price of $93.06 (range $92.98 to $93.14).
The option vests in 16 quarterly installments from 02/02/2016.